Streetbeat News

Products Services

KPTI

Karyopharm Therapeutics Inc announced updated exploratory subgroup analyses from the SIENDO study in patients with advanced or recurrent TP53 wild-type endometrial cancer. The analysis showed a promising efficacy signal with a median progression-free survival (PFS) of 27.4 months for selinexor-treated patients. The data provides further rationale for the ongoing pivotal Phase 3 study of selinexor as maintenance therapy. Karyopharm is currently enrolling patients in this study. However, KPTI shares are down 4.09% at $1.53.

Portfolio Pulse from Vandana Singh

July 26, 2023 | 1:33 pm

AAPL

AMZN

GOOG

META

MSFT

Meta Platforms, Microsoft, Amazon Web Services, and TomTom have collaborated to form the Overture Maps Foundation, aiming to create an alternative to Google and Apple Maps. The foundation has collected 59 million points of interest and made the data available for free as a base layer for a new map application. This move could provide more flexibility for companies to build their software on top of it, compared to using Google's or Apple's maps as a service.

Portfolio Pulse from Anusuya Lahiri

July 26, 2023 | 1:29 pm

ICE

Util has launched a new AI-driven Universal Impact and SDG for Fixed Income offering in collaboration with Intercontinental Exchange (ICE). The new offering will provide evidence-based impact data across funds, indexes, and many public and private companies.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 1:26 pm

NEWR

New Relic has launched an Interactive Application Security Testing service. The patented deterministic technique is said to deliver near zero false positives and proof-of-exploit, accelerating security testing and enabling development, operations, and security teams to ship secure code faster.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 1:23 pm

KO

During a conference call, a Coca-Cola executive reported strong demand for some of the company's juice businesses in China and India.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 1:22 pm

AMZN

NTAP

S

SentinelOne has launched a new cloud data security product line, offering high-speed malware detection for Amazon S3 and NetApp. This new product line aims to revolutionize protection as threats evolve.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 1:19 pm

LIAN

Lianbio's partner, Tarsus Pharmaceuticals, has received FDA approval for Xdemvy 0.25% for the treatment of Demodex Blepharitis. This approval could potentially boost Lianbio's revenues and market position.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 1:14 pm

BWXT

BWXT has been contracted to provide a nuclear reactor engine and fuel for a DARPA space project. The size of the contract has not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 1:13 pm

CEG

JCI

Johnson Controls (NYSE:JCI) and Constellation (NASDAQ:CEG) have announced an agreement to support the development of two new solar plants in Pennsylvania. The agreement will match the power needs of four major Johnson Controls manufacturing and research and development facilities. The collaboration will support Johnson Controls' goal of 100% renewable energy and net zero operations by 2040. The new renewable energy agreement will help reduce Johnson Controls' carbon footprint by more than 14,000 metric tons annually.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 1:09 pm

ABBV

AMGN

NVS

Seven pharmaceutical companies have launched biosimilars of AbbVie's arthritis drug Humira, sparking calls for reform in drug pricing intermediaries. Despite the increased competition, prices remain high, highlighting the need for reform in the pharmaceutical supply chain. The Biden administration has prioritized lowering drug prices and passed the Inflation Reduction Act, targeting pharmacy benefit managers (PBMs). Amgen, which launched its biosimilar to Humira, argues that PBMs favor higher list prices for subsequent after-market discounts. Novartis's Sandoz unit has also launched biosimilars.

Portfolio Pulse from Vandana Singh

July 26, 2023 | 1:06 pm